SONOMA PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent of $235.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2026-06-30 was $235.00K, a 70.84% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2026-03-31 was -$52.00K, a 129.21% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2025-12-31 was $174.00K.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2025-09-30 was $205.00K.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2026 was $1.13M.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2025 was -$1.65M, a 337.84% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2024 was $695.00K, a 22.26% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2023 was $894.00K, a 234.83% increase from fiscal 2022.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235.00K 10-Q · filed 2026-08-06 | $183.00K derived: sum of 2 quarters · filed 2026-08-06 | $357.00K derived: sum of 3 quarters · filed 2026-08-06 | $562.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $122.00K derived: sum of 2 quarters · filed 2026-06-16 | $327.00K derived: sum of 3 quarters · filed 2026-06-16 | $1.13M 10-K · filed 2026-06-16 | ||
| 2025-12-31 | $174.00K 10-Q · filed 2026-02-10 | $379.00K derived: sum of 2 quarters · filed 2026-02-10 | $1.19M 10-Q · filed 2026-02-10 | $1.36M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-09-30 | $205.00K 10-Q · filed 2025-11-04 | $1.01M 10-Q · filed 2025-11-04 | $1.19M derived: sum of 3 quarters · filed 2026-08-06 | $832.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $806.00K 10-Q · filed 2026-08-06 | $984.00K derived: sum of 2 quarters · filed 2026-08-06 | $627.00K derived: sum of 3 quarters · filed 2026-08-06 | $34.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | -$179.00K derived: sum of 2 quarters · filed 2026-06-16 | -$772.00K derived: sum of 3 quarters · filed 2026-06-16 | -$1.65M 10-K · filed 2026-06-16 | ||
| 2024-12-31 | -$357.00K 10-Q · filed 2026-02-10 | -$950.00K derived: sum of 2 quarters · filed 2026-02-10 | -$1.83M 10-Q · filed 2026-02-10 | -$1.73M derived: sum of 4 quarters · filed 2026-02-10 | ||
| 2024-09-30 | -$593.00K 10-Q · filed 2025-11-04 | -$1.47M 10-Q · filed 2025-11-04 | -$1.37M derived: sum of 3 quarters · filed 2025-11-04 | -$1.08M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | -$881.00K 10-Q · filed 2025-08-07 | -$781.00K derived: sum of 2 quarters · filed 2025-08-07 | -$484.00K derived: sum of 3 quarters · filed 2025-08-07 | -$697.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $397.00K derived: sum of 2 quarters · filed 2025-06-17 | $184.00K derived: sum of 3 quarters · filed 2025-06-17 | $695.00K 10-K · filed 2025-06-17 | ||
| 2023-12-31 | $297.00K 10-Q · filed 2025-02-05 | $84.00K derived: sum of 2 quarters · filed 2025-02-05 | $595.00K 10-Q · filed 2025-02-05 | $1.35M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2023-09-30 | -$213.00K 10-Q · filed 2024-11-07 | $298.00K 10-Q · filed 2024-11-07 | $1.06M derived: sum of 3 quarters · filed 2024-11-07 | $1.29M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $511.00K 10-Q · filed 2024-08-08 | $1.27M derived: sum of 2 quarters · filed 2024-08-08 | $1.50M derived: sum of 3 quarters · filed 2024-08-08 | $1.47M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $993.00K derived: sum of 2 quarters · filed 2024-06-17 | $959.00K derived: sum of 3 quarters · filed 2024-06-17 | $894.00K 10-K · filed 2024-06-17 | ||
| 2022-12-31 | $235.00K 10-Q · filed 2024-02-08 | $201.00K derived: sum of 2 quarters · filed 2024-02-08 | $136.00K 10-Q · filed 2024-02-08 | $395.00K derived: sum of 4 quarters · filed 2024-02-08 | ||
| 2022-09-30 | -$34.00K 10-Q · filed 2023-11-13 | -$99.00K 10-Q · filed 2023-11-13 | $160.00K derived: sum of 3 quarters · filed 2023-11-13 | $95.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$65.00K 10-Q · filed 2023-08-10 | $194.00K derived: sum of 2 quarters · filed 2023-08-10 | $129.00K derived: sum of 3 quarters · filed 2023-08-10 | -$105.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $194.00K derived: sum of 2 quarters · filed 2023-06-21 | -$40.00K derived: sum of 3 quarters · filed 2023-06-21 | $267.00K 10-K · filed 2023-06-21 | ||
| 2021-12-31 | -$65.00K 10-Q · filed 2023-02-14 | -$299.00K derived: sum of 2 quarters · filed 2023-02-14 | $8.00K 10-Q · filed 2023-02-14 | -$336.00K derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-09-30 | -$234.00K 10-Q · filed 2022-11-14 | $73.00K 10-Q · filed 2022-11-14 | -$271.00K derived: sum of 3 quarters · filed 2022-11-14 | $749.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $307.00K 10-Q · filed 2022-08-11 | -$37.00K derived: sum of 2 quarters · filed 2022-08-11 | $983.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.17M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | $676.00K derived: sum of 2 quarters · filed 2022-07-13 | $864.00K derived: sum of 3 quarters · filed 2022-07-13 | $1.03M 10-K · filed 2022-07-13 | ||
| 2020-12-31 | $1.02M 10-Q · filed 2022-02-11 | $1.21M derived: sum of 2 quarters · filed 2022-02-11 | $1.38M 10-Q · filed 2022-02-11 | -$54.00K derived: sum of 4 quarters · filed 2022-02-11 | ||
| 2020-09-30 | $188.00K 10-Q · filed 2021-11-15 | $355.00K 10-Q · filed 2021-11-15 | -$1.07M derived: sum of 3 quarters · filed 2021-11-15 | -$810.00K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $167.00K 10-Q · filed 2021-08-16 | $159.00K 10-Q · filed 2020-08-14 | -$1.26M derived: sum of 2 quarters · filed 2021-08-16 | -$998.00K derived: sum of 3 quarters · filed 2021-08-16 | -$1.16M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | -$1.17M derived: sum of 2 quarters · filed 2021-07-14 | -$1.33M derived: sum of 3 quarters · filed 2021-07-14 | -$1.26M 10-K · filed 2021-07-14 | ||
| 2019-12-31 | $264.00K 10-Q · filed 2021-02-16 | $101.00K derived: sum of 2 quarters · filed 2021-02-16 | $168.00K 10-Q · filed 2021-02-16 | $237.00K derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-09-30 | -$163.00K 10-Q · filed 2020-11-20 | -$96.00K 10-Q · filed 2020-11-20 | -$27.00K derived: sum of 3 quarters · filed 2020-11-20 | -$318.00K derived: sum of 4 quarters · filed 2020-11-20 | ||
| 2019-06-30 | $67.00K 10-Q/A · filed 2020-11-17 | $136.00K derived: sum of 2 quarters · filed 2020-11-17 | -$155.00K derived: sum of 3 quarters · filed 2020-11-17 | $195.00K derived: sum of 4 quarters · filed 2020-11-17 | ||
| 2019-03-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | -$222.00K derived: sum of 2 quarters · filed 2020-07-10 | $128.00K derived: sum of 3 quarters · filed 2020-07-10 | -$374.00K 10-K · filed 2020-07-10 | $374.00K 10-K · filed 2019-07-01 | |
| 2018-12-31 | -$291.00K 10-Q · filed 2020-02-14 | $59.00K derived: sum of 2 quarters · filed 2020-02-14 | -$443.00K 10-Q · filed 2020-02-14 | -$18.00K derived: sum of 4 quarters · filed 2020-02-14 | ||
| 2018-09-30 | $350.00K 10-Q · filed 2019-11-14 | -$152.00K 10-Q · filed 2019-11-14 | $273.00K derived: sum of 3 quarters · filed 2019-11-14 | -$104.00K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$502.00K 10-Q · filed 2019-08-13 | -$77.00K derived: sum of 2 quarters · filed 2019-08-13 | -$454.00K derived: sum of 3 quarters · filed 2019-08-13 | -$499.00K derived: sum of 4 quarters · filed 2019-08-13 | ||
| 2018-03-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | $48.00K derived: sum of 2 quarters · filed 2019-07-01 | $3.00K derived: sum of 3 quarters · filed 2019-07-01 | $203.00K 10-K · filed 2019-07-01 | ||
| 2017-12-31 | -$377.00K 10-Q · filed 2019-02-14 | -$422.00K derived: sum of 2 quarters · filed 2019-02-14 | -$222.00K 10-Q · filed 2019-02-14 | $271.00K derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-09-30 | -$45.00K 10-Q · filed 2018-11-08 | $155.00K 10-Q · filed 2018-11-08 | $648.00K derived: sum of 3 quarters · filed 2018-11-08 | $232.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | $200.00K 10-Q · filed 2018-08-08 | $693.00K derived: sum of 2 quarters · filed 2018-08-08 | $277.00K derived: sum of 3 quarters · filed 2018-08-08 | $109.00K derived: sum of 4 quarters · filed 2018-08-08 | ||
| 2017-03-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $77.00K derived: sum of 2 quarters · filed 2018-06-26 | -$91.00K derived: sum of 3 quarters · filed 2018-06-26 | -$324.00K 10-K · filed 2018-06-26 | ||
| 2016-12-31 | -$416.00K 10-Q · filed 2018-02-14 | -$584.00K derived: sum of 2 quarters · filed 2018-02-14 | -$817.00K 10-Q · filed 2018-02-14 | -$772.00K derived: sum of 4 quarters · filed 2018-02-14 | ||
| 2016-09-30 | -$168.00K 10-Q · filed 2017-11-14 | -$401.00K 10-Q · filed 2017-11-14 | -$356.00K derived: sum of 3 quarters · filed 2017-11-14 | -$424.00K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | -$233.00K 10-Q · filed 2017-08-08 | -$188.00K derived: sum of 2 quarters · filed 2017-08-08 | -$256.00K derived: sum of 3 quarters · filed 2017-08-08 | -$509.00K derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-03-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | -$23.00K derived: sum of 2 quarters · filed 2017-06-28 | -$276.00K derived: sum of 3 quarters · filed 2017-06-28 | -$347.00K 10-K · filed 2017-06-28 | ||
| 2015-12-31 | -$68.00K 10-Q · filed 2017-02-17 | -$321.00K derived: sum of 2 quarters · filed 2017-02-17 | -$392.00K 10-Q · filed 2017-02-17 | |||
| 2015-09-30 | -$253.00K 10-Q · filed 2016-11-15 | -$324.00K 10-Q · filed 2016-11-15 | ||||
| 2015-06-30 | -$71.00K 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | -$438.00K 10-K · filed 2016-06-21 | |||||
| 2014-03-31 | -$78.00K 10-K · filed 2015-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |